^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    DRUG:

    NK92-CD16-158V

    i
    Other names: NK92-CD16-158V, CD-16 NK-92 cells, NK-92 [CD16.158V, ER IL-2], hanK for infusion, haNK, haNK cell therapy, high-affinity CD16-expressing natural killer cell therapy, high-affinity natural killer cell therapy
    Associations
    News
    Trials
    Company:
    ImmunityBio
    Drug class:
    NK cell stimulant
    Related drugs:
    Associations
    News
    Trials